MPs call for better safeguards on antipsychotic use in care homesBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39566.573079.4E (Published 01 May 2008) Cite this as: BMJ 2008;336:983
- Lynn Eaton
The government should take action to stop dangerous prescribing of antipsychotic drugs to people with dementia, says a report from a group of MPs.
The all party parliamentary group on dementia says that the government should use its national dementia strategy, which is due to be published in October, to tackle the problem and that the National Institute for Health and Clinical Excellence should review use of the drugs.
“Antipsychotics can double the risk of death and triple the risk of stroke in people with dementia, heavily sedate them, and accelerate cognitive decline,” said Jeremy Wright, the group’s chairman. “Best practice guidelines are not enough: safeguards must be …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial